Cargando…
Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment
Deep understanding of the SARS-CoV-2 effects on host molecular pathways is paramount for the discovery of early biomarkers of outcome of coronavirus disease 2019 (COVID-19) and the identification of novel therapeutic targets. In that light, we generated metabolomic data from COVID-19 patient blood u...
Autores principales: | Rendeiro, André F., Vorkas, Charles Kyriakos, Krumsiek, Jan, Singh, Harjot K., Kapadia, Shashi N., Cappelli, Luca Vincenzo, Cacciapuoti, Maria Teresa, Inghirami, Giorgio, Elemento, Olivier, Salvatore, Mirella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790058/ https://www.ncbi.nlm.nih.gov/pubmed/35095900 http://dx.doi.org/10.3389/fimmu.2021.809937 |
Ejemplares similares
-
Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression
por: Rendeiro, André F, et al.
Publicado: (2020) -
Longitudinal immune profiling of mild and severe COVID-19 reveals
innate and adaptive immune dysfunction and provides an early prediction tool for
clinical progression
por: Rendeiro, André F., et al.
Publicado: (2020) -
519. Immune responses and COVID-19 severity
por: salvatore, mirella, et al.
Publicado: (2020) -
The spatio-temporal landscape of lung pathology in SARS-CoV-2 infection
por: Rendeiro, André Figueiredo, et al.
Publicado: (2020) -
The road from Rous sarcoma virus to precision medicine
por: Elemento, Olivier
Publicado: (2021)